Stocks Overview

LAST PRICE
41.5300
TODAY'S CHANGE (%)
Trending Down-0.4200 (-1.0012%)

Bid / Lots
41.5800/ 1
Ask / Lots
44.4000/ 2
Open / Previous Close
42.0000 / 41.9500
Day Range
Low 41.2000
High 44.7900
52 Week Range
Low 26.6100
High 75.0167
Volume
611,759
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 41.95
Time	Volume	GPCR
09:32 ET	11087	41.775
09:34 ET	1800	41.7981
09:36 ET	600	42.1476
09:38 ET	1639	42.81
09:39 ET	300	42.26
09:41 ET	3100	42.9
09:43 ET	300	42.75
09:45 ET	7200	43.58
09:48 ET	2176	43.28
09:50 ET	3379	43.38
09:52 ET	6985	43.4508
09:54 ET	3696	43.32
09:56 ET	1220	43.375
09:57 ET	2000	43.375
09:59 ET	1941	43.98
10:01 ET	13472	44.27
10:03 ET	900	44.49
10:06 ET	1397	44.545
10:08 ET	13613	44.21
10:10 ET	10168	43.65
10:12 ET	2668	43.605
10:14 ET	1900	43.72
10:15 ET	915	43.69
10:17 ET	7210	44.1077
10:19 ET	8195	43.87
10:21 ET	1506	43.72
10:24 ET	1460	43.935
10:26 ET	1500	43.89
10:28 ET	3962	43.765
10:30 ET	5318	43.715
10:32 ET	1400	43.675
10:33 ET	35439	42.485
10:35 ET	5213	42.6
10:37 ET	300	42.495
10:39 ET	1300	42.365
10:42 ET	2152	42.26
10:44 ET	1400	42.165
10:46 ET	228	42.0199
10:48 ET	100	42.07
10:50 ET	2880	41.76
10:51 ET	1300	41.845
10:53 ET	3741	41.6
10:55 ET	10800	41.95
10:57 ET	3819	42.28
11:00 ET	4972	42.29
11:02 ET	5299	42.44
11:04 ET	400	42.47
11:06 ET	1100	42.51
11:08 ET	5625	42.41
11:09 ET	1150	42.4
11:11 ET	1000	42.34
11:13 ET	721	42.38
11:15 ET	300	42.27
11:18 ET	2871	42.55
11:20 ET	3013	42.66
11:22 ET	800	42.475
11:24 ET	900	42.475
11:26 ET	550	42.4
11:27 ET	1500	42.455
11:29 ET	4746	42.8
11:31 ET	1550	42.87
11:33 ET	1100	42.94
11:36 ET	800	42.94
11:38 ET	100	42.83
11:42 ET	1708	42.81
11:44 ET	1300	42.89
11:45 ET	300	42.9194
11:47 ET	1500	42.88
11:49 ET	500	42.94
11:51 ET	5818	43.125
11:54 ET	100	43.17
11:56 ET	330	43.265
11:58 ET	1200	43.255
12:00 ET	100	43.25
12:02 ET	400	43.21
12:03 ET	900	43.12
12:05 ET	200	43.11
12:07 ET	100	43.07
12:09 ET	400	43.155
12:12 ET	3735	42.82
12:14 ET	737	42.81
12:16 ET	250	42.8271
12:18 ET	100	42.9
12:20 ET	100	43
12:21 ET	100	42.91
12:23 ET	2619	42.92
12:25 ET	100	42.99
12:27 ET	2500	43
12:32 ET	800	42.87
12:36 ET	1163	42.7
12:38 ET	687	42.7698
12:39 ET	600	42.94
12:43 ET	592	42.995
12:45 ET	1600	43.005
12:48 ET	112	43.005
12:50 ET	706	43
12:52 ET	500	42.975
12:56 ET	1000	42.91
12:57 ET	641	42.8075
12:59 ET	400	42.84
01:01 ET	100	42.845
01:03 ET	200	42.845
01:06 ET	100	42.888
01:10 ET	100	42.84
01:14 ET	400	42.88
01:15 ET	1425	42.75
01:17 ET	3811	42.625
01:19 ET	600	42.515
01:21 ET	400	42.195
01:24 ET	840	42.235
01:26 ET	200	42.32
01:28 ET	200	42.34
01:30 ET	385	42.33
01:32 ET	600	42.34
01:35 ET	500	42.32
01:39 ET	925	42.455
01:42 ET	250	42.4414
01:44 ET	1700	42.365
01:46 ET	500	42.52
01:48 ET	100	42.52
01:50 ET	1700	42.39
01:51 ET	296	42.485
01:53 ET	550	42.47
01:57 ET	841	42.515
02:00 ET	2280	42.535
02:02 ET	300	42.52
02:04 ET	200	42.51
02:06 ET	300	42.55
02:08 ET	550	42.55
02:09 ET	1300	42.395
02:11 ET	300	42.39
02:13 ET	100	42.39
02:15 ET	200	42.3501
02:18 ET	530	42.3969
02:20 ET	420	42.455
02:22 ET	600	42.485
02:24 ET	1100	42.5
02:26 ET	200	42.545
02:27 ET	616	42.5
02:29 ET	400	42.43
02:31 ET	206	42.455
02:33 ET	708	42.39
02:38 ET	200	42.46
02:40 ET	1200	42.53
02:42 ET	300	42.51
02:45 ET	450	42.52
02:47 ET	2340	42.5554
02:49 ET	220	42.515
02:51 ET	4188	42.43
02:54 ET	491	42.44
02:56 ET	1400	42.515
02:58 ET	1374	42.405
03:00 ET	300	42.38
03:02 ET	1200	42.3
03:03 ET	100	42.24
03:05 ET	1060	42.25
03:07 ET	100	42.235
03:09 ET	440	42.24
03:12 ET	1950	42.275
03:14 ET	1700	42.28
03:16 ET	500	42.335
03:18 ET	500	42.34
03:20 ET	908	42.295
03:21 ET	845	42.24
03:23 ET	709	42.225
03:25 ET	1129	42.07
03:27 ET	936	42.07
03:30 ET	834	42.04
03:32 ET	254	42.075
03:34 ET	1100	42.1089
03:36 ET	2700	42.13
03:38 ET	1000	42.135
03:39 ET	6390	42
03:41 ET	2950	41.81
03:43 ET	2450	41.77
03:45 ET	7164	41.65
03:48 ET	2999	41.69
03:50 ET	3180	41.66
03:52 ET	7833	41.64
03:54 ET	5623	41.585
03:56 ET	5149	41.6
03:57 ET	6329	41.75
03:59 ET	62031	41.53

Data delayed at least 15 minutes.

Sep 23, 2024
- DJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 8:45AM ET on Monday Sep 23, 2024 by Dow Jones
  8:45AM ET on Monday Sep 23, 2024 by Dow Jones
- DJ Structure Therapeutics Initiated at Overweight by Morgan Stanley, from 8:17AM ET on Monday Sep 23, 2024 by Dow Jones
  8:17AM ET on Monday Sep 23, 2024 by Dow Jones
Sep 20, 2024
- DJ High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill -- WSJ, from 1:17PM ET on Friday Sep 20, 2024 by Dow Jones
  1:17PM ET on Friday Sep 20, 2024 by Dow Jones
Sep 17, 2024
- DJ Structure Therapeutics Names Blai Coll as Chief Medical Officer, from 4:21PM ET on Tuesday Sep 17, 2024 by Dow Jones
  4:21PM ET on Tuesday Sep 17, 2024 by Dow Jones
- Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer, from 4:05PM ET on Tuesday Sep 17, 2024 by Dow Jones
  4:05PM ET on Tuesday Sep 17, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesGPCR Structure Therapeutics Inc	2.4B	-18.6x	---
United StatesEWTX Edgewise Therapeutics Inc	2.4B	-17.0x	---
United StatesCGON CG Oncology Inc	2.4B	-31.5x	---
United StatesSWTX SpringWorks Therapeutics Inc	2.4B	-7.3x	---
United StatesCLDX Celldex Therapeutics Inc	2.4B	-12.0x	---
United StatesVERA Vera Therapeutics Inc	2.5B	-20.7x	---
As of 2024-09-26

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.

Contact Information

Headquarters: 611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
Phone: ---
Fax: ---

Executives

Independent Chairman of the Board: Daniel Welch
Chief Executive Officer, Director: Raymond Stevens
Chief Financial Officer: Jun Yoon
Chief Technology Officer: Yingli Ma
Chief Scientific Officer: Xichen Lin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.4B
Revenue (TTM)	$0.00
Shares Outstanding	57.2M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	$-2.24
Book Value	$9.76
P/E Ratio	-18.6x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Structure Therapeutics Inc
NASDAQ:GPCRUnited States

Search Criteria

Charts

Recent News

Sep 23, 2024

DJ Structure Therapeutics Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 8:45AM ET on Monday Sep 23, 2024 by Dow Jones

DJ Structure Therapeutics Initiated at Overweight by Morgan Stanley, from 8:17AM ET on Monday Sep 23, 2024 by Dow Jones

Sep 20, 2024

DJ High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill -- WSJ, from 1:17PM ET on Friday Sep 20, 2024 by Dow Jones

Sep 17, 2024

DJ Structure Therapeutics Names Blai Coll as Chief Medical Officer, from 4:21PM ET on Tuesday Sep 17, 2024 by Dow Jones

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer, from 4:05PM ET on Tuesday Sep 17, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar